Japan 2014 Budget: ¥95.3 Billion Of ¥30 Trillion Reserved For Medical Innovations
This article was originally published in PharmAsia News
With a quickly aging society and a consumption tax hike looming, the Japanese 2014 budget for social security costs in 2014 topped ¥30 trillion for the first time.
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.